Overview
Wazhma Nasiri is an Endocrinologist in North Babylon, New York. Dr. Nasiri is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Hypercalcemia, Milk-Alkali Syndrome, Smoldering Multiple Myeloma, and Obesity in Children.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Smoldering Multiple Myeloma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1476 Deer Park Ave Ste 4, North Babylon, NY 11703
180 Pulaski Rd Ste E1-930, Huntington Station, NY 11746
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Azeez Farooki is an Endocrinologist in New York, New York. Dr. Farooki is rated as a Distinguished provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Melorheostosis with Osteopoikilosis, Melorheostosis, and Orchiectomy.
Stonybrook Dialysis Clinic
Brooke Learned is an Endocrinologist in East Setauket, New York. Dr. Learned is rated as an Experienced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Hypercalcemia, Milk-Alkali Syndrome, Smoldering Multiple Myeloma, and Hypervitaminosis D.
Mount Sinai
Emily Gallagher is an Endocrinologist in New York, New York. Dr. Gallagher is rated as an Advanced provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Secondary Adrenal Insufficiency, Obesity, Type 2 Diabetes (T2D), and Addison's Disease.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HypercalcemiaDr. Nasiri isExperienced. Learn about Hypercalcemia.
- Milk-Alkali SyndromeDr. Nasiri isExperienced. Learn about Milk-Alkali Syndrome.
- Obesity in ChildrenDr. Nasiri isExperienced. Learn about Obesity in Children.
- Smoldering Multiple MyelomaDr. Nasiri isExperienced. Learn about Smoldering Multiple Myeloma.